Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
512 µM
Hemolytic
Cytotoxic
0% Hemolysis | 512 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2. | Int J Pept Res Ther | 2019